Hovnanian Enterprises Return on Equity

Hovnanian Enterprises (HOV) currently reports a ROE of 2.17%. That is below the Healthcare sector average of 22.01%. Use the charts on this page to explore Hovnanian Enterprises's ROE history and peer comparisons.

Hovnanian Enterprises's ROE of 2.17% is lower than the Healthcare sector average of 22.01%. That is roughly 90.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Hovnanian Enterprises's current 2.17% should be judged against Healthcare norms (sector average: 22.01%) and against HOV's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 2.17%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 22.01%. From there, open related valuation or income-statement pages for Hovnanian Enterprises, and consider following HOV for alerts when major investors trade the stock.

Hovnanian Enterprises is classified in the Healthcare sector. On ROE, it currently shows 2.17% versus a sector average near 22.01%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing HOV with unrelated industries.